Company news

Nkarta, Inc. news in 2022

Nkarta, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Nkarta Announces Updated Clinical Data on Anti-CD19 Allogeneic CAR-NK Cell Therapy NKX019 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

December 4, 2022

Nkarta to Host Conference Call to Discuss Updated Clinical Data from NKX019 NK Cell Therapy Program

December 1, 2022

Nkarta Reports Third Quarter 2022 Financial Results and Corporate Highlights

November 8, 2022

Nkarta Presents Data Supporting Engineered NK Cell Based Combination Therapies and Next Generation Commercial-Scale Manufacturing Platform at SITC 37th Annual Meeting

November 6, 2022

Nkarta Reports Second Quarter 2022 Financial Results and Corporate Highlights

August 10, 2022

Nkarta Announces Key Senior Leadership Team Appointments

July 24, 2022

Nkarta Appoints David R. Shook, MD, as Vice President, Clinical Development

May 15, 2022

Nkarta Reports First Quarter 2022 Financial Results and Corporate Highlights

May 11, 2022

Nkarta Announces Closing of Upsized Public Offering of Common Stock and Underwriters’ Full Exercise of Option to Purchase Additional Shares

April 27, 2022

Nkarta Announces Proposed Public Offering of Common Stock

April 24, 2022

Nkarta Announces Pricing of Upsized Public Offering of Common Stock

April 24, 2022

Nkarta Announces Positive Preliminary Dose Finding Data for Two Lead Engineered Natural Killer Cell Programs

April 24, 2022

Nkarta to Host Conference Call Highlighting Preliminary Clinical Data from Two Lead NK Cell Therapy Candidates

April 21, 2022

Nkarta Presents New Preclinical Data from Engineered NK Cell Platform at AACR Annual Meeting 2022

April 7, 2022

Nkarta Appoints Manufacturing Technology Executive, Angela Thedinga, to Board of Directors

March 28, 2022

Nkarta Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights

March 16, 2022

Nkarta to Present Preclinical Data from Engineered NK Cell Platform at the American Association for Cancer Research 2022 Annual Meeting

March 7, 2022

Decks in 2022